HUMAN DNASE RESISTANT TO ACTIN INHIBITION

摘要

This invention relates to a novel human deoxyribonuclease, referred to as LS - DNase, that is relatively resistant to inhibition by actin, as compared to human DNase I. The invention provides nucleic acid sequences encoding LS-DNase, thereby enabling the production of LS-DNase by recombinant DNA methods in quantities sufficient for clinical us e. The invention also relates to pharmaceutical compositions and therapeutic uses of LS-DNase.